Related references
Note: Only part of the references are listed.EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial
Josep Ordi-Ros et al.
ANNALS OF INTERNAL MEDICINE (2019)
Management of antiphospholipid syndrome
Imad Uthman et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism
Clive Kearon et al.
BLOOD (2018)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Diagnosis and Management of the Antiphospholipid Syndrome
David Garcia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances
Savino Sciascia et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy
William G. Jackson et al.
BLOOD ADVANCES (2017)
Antiphospholipid syndrome
M. Khamashta et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2016)
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER II, and RE-MEDY™
Samuel Z. Goldhaber et al.
VASCULAR MEDICINE (2016)
Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome
Nicolas Noel et al.
AUTOIMMUNITY REVIEWS (2015)
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio
Colum F. Amory et al.
CEREBROVASCULAR DISEASES (2015)
Distinctions Between Diagnostic and Classification Criteria?
Rohit Aggarwal et al.
ARTHRITIS CARE & RESEARCH (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review
David Garcia et al.
BLOOD (2013)
Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative
Emmanuel Coloma Bazan et al.
IMMUNOLOGIC RESEARCH (2013)
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Maarten G. Lansberg et al.
CHEST (2012)
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
G. Ruiz-Irastorza et al.
LUPUS (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities
Maria Rita Taliani et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
Clive Kearon et al.
BLOOD (2008)
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Marc A. Rodger et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism
K Wåhlander et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Evaluation of the quality of prognosis studies in systematic reviews
JA Hayden et al.
ANNALS OF INTERNAL MEDICINE (2006)
Management of antiphospholipid antibody syndrome - A systematic review
W Lim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS)
G Finazzi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation - An 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia
PRJ Ames et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor
C Kearon et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
MA Crowther et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
T Baglin et al.
LANCET (2003)
Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome
RHWM Derksen et al.
NEUROLOGY (2003)
Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera et al.
ARTHRITIS AND RHEUMATISM (2002)
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
JP Mohr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
